Author Affiliations: Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina (firstname.lastname@example.org).
In Reply: The main objective of our study was to identify predictors of 30-day readmission among US patients vs those in other countries with lower readmission rates. Although country-level length of stay was an important predictor, we disagree with Dr Andraws that US patients might be receiving suboptimal treatment. By being aware that shorter length of stay may be associated with readmission among some patients, physicians can implement improved patient education and transitional care processes and better identify those higher-risk patients that may benefit from longer hospitalization.
Kociol RD, Lopes RD, Patel MR. International Variation in Readmission After Myocardial Infarction—Reply. JAMA. 2012;307(16):1690-1691. doi:10.1001/jama.2012.531